Abstract:Epilepsy and headache are the two most common neurologic disorders affecting individuals of all ages worldwide. They constitute an important health and socioeconomic problem 1,2 . Approximately 50 million people suffer from epilepsy 3 , while in the adult population the prevalence of active headache is around 46% 2 . Drug treatment of epilepsy, with antiepileptic drugs, and headache, with prophylactic drugs, is prolonged in most cases (years to decades). Moreover, although for both pathologies it is recommende… Show more
“…Additionally common medications such as Sodium Valporate, Topiramate and Gabapentin are used for treating of both disorders (1,2). Their co-morbidity has been confirmed by several studies (1)(2)(3)(4)(5)(6). Ottman et al have postulated that the prevalence of migraine among patients with epilepsy is about 2.4 times higher than that of the normal population (7) and also the chance of migraine headache in epileptic patients is higher than the normal population (i.e.…”
“…Additionally common medications such as Sodium Valporate, Topiramate and Gabapentin are used for treating of both disorders (1,2). Their co-morbidity has been confirmed by several studies (1)(2)(3)(4)(5)(6). Ottman et al have postulated that the prevalence of migraine among patients with epilepsy is about 2.4 times higher than that of the normal population (7) and also the chance of migraine headache in epileptic patients is higher than the normal population (i.e.…”
In Colombia, antiepileptic drugs are being used for indications other than those originally intended. Monotherapy is the most commonly used treatment approach, together with the use of classic antiepileptic drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.